1Luscher TF. Endothelial dysfunction: the role and impact of the renin-angiolensin system. Heart,2000,84(Suppl 1) : 120.
2Herizi A, Jover B, Bouriquet N, et al. Prevention of the cardiovascular and renal effects of angiotensin Ⅱ by endothelin blockade. Hypertension,1998,31:10.
3Suchitra M B, Balakrishnan SM, Wang HD, et al. Effect of an endothelin antagonist on hemodynamic responses to angiotensin Ⅱ. Hypertension,1996,28:806.
4Garre DG, Ortega MR, Ortego MR, et al. Effects and interactions of endothelin-1 and angiotensin Ⅱ on matrix protein expression and synthesis and mesangial cell growth. Hypertension, 1996,27:885.
5d'Uscio LV. Moreau P, Shaw S, et al. Effects of chronic EFA receptor blockade in agiotensin Ⅱ-induced hypertension. Hypertension, 1997, 20:435.
6Fujisaki H,Ito H,Hirata Y, et al. Natriuretic peptides inhibit angiotensin Ⅱ-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression.J Clin Invest,1995,96:1059.
7Moe O,Tejedor A, Campbell WB, et al.Effects of endothelin on in vitro renin secretion. Am J Physiol, 1991,260: E521.
8Matsumura Y, Nakase K, Ikegawa R, et al. the endothelium derived vasoconstrictor endothelin inhibits renin release in vitro. Life Sci, 1989,44:149.
9Takagi M, Matshoka H, Atarashi K, et al. Endothelin, a new inhibitor of rennin release. Biochem Biophys Res Commun, 1988,157:1164.
